Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07602842
PHASE1/PHASE2

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

Sponsor: InduPro, Inc.

View on ClinicalTrials.gov

Summary

This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutaneous).

Official title: A Phase 1/2 Open-label Study of IDP-001 in Advanced or Metastatic Squamous Cell Lung Cancer and Other Solid Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

132

Start Date

2026-07-08

Completion Date

2028-12

Last Updated

2026-09-03

Healthy Volunteers

No

Interventions

DRUG

IDP-001

IV infusion

Locations (6)

START Los Angeles

Los Angeles, California, United States

Florida Cancer Specialists

Sarasota, Florida, United States

Community Cancer Center North

Indianapolis, Indiana, United States

Roswell Park Cancer Institute

Buffalo, New York, United States

START New York Long Island

Lake Success, New York, United States

START Dallas Forth Worth

Fort Worth, Texas, United States